Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

  1. Alvarez-Twose, I.
  2. Matito, A.
  3. Morgado, J.M.
  4. Sánchez-Muñoz, L.
  5. Jara-Acevedo, M.
  6. García-Montero, A.
  7. Mayado, A.
  8. Caldas, C.
  9. Teodósio, C.
  10. Muñoz-González, J.I.
  11. Mollejo, M.
  12. Escribano, L.
  13. Orfao, A.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2017

Alea: 8

Zenbakia: 40

Orrialdeak: 68950-68963

Mota: Artikulua

DOI: 10.18632/ONCOTARGET.10711 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus